Abstract
Factors outside diet and physical activity can contribute to weight gain. Most notably, many commonly used medications have a potential adverse effect of weight gain, which can lead to iatrogenic obesity – that is, obesity being caused, or contributed to, by medical treatment. Clinicians should become aware of medications with a high risk for weight gain and alternative medication options.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Petrin C, Kahan S, Turner M, et al. Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals. Obes Sci Pract. 2016;2(3):266–71.
Apovian C, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.
Domecq JP, Prutsky G, Leppin A, et al. Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:363–70.
Bahr SM, Weidemann BJ, Castro AN, et al. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine. 2015;2:1725–34.
Silverman BL, Martin W, Memisoglu A, et al. A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers. Schizophrenia Res. 2018;195:245–51.
Hsieh A, Sweeting A, Suryawanshi A, Caterson ID. Drugs that cause weight gain and clinical alternatives to their use. In: Bray GA, Bouchard C, editors. Handbook of obesity. Boca Raton: CRC Press; 2014.
Paneni F, Luscher TF. Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. Am J Med. 2017;130(6):S18–29.
Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259–72.
Lord CC, et al. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. J Clin Invest. 2017;127(9):3402–6.
Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial. JAMA Psychiat. 2017;74(7):719–28.
Schwartz TL, Beale M. Psychotropic drug-induced weight gain alleviated with orlistat: a case series. Psychopharmacol Bull. 2003;37:5–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kahan, S. (2019). Iatrogenic Obesity. In: Morton, J., Brethauer, S., DeMaria, E., Kahan, S., Hutter, M. (eds) Quality in Obesity Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-25173-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-25173-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25172-7
Online ISBN: 978-3-030-25173-4
eBook Packages: MedicineMedicine (R0)